AI can Accelerate Search for More Effective Alzheimer's Medicines by Streamlining Clinical Trials
Using AI allowed the team to split trial participants into two groups: either slowly or rapidly progressing towards Alzheimer’s disease.
Using AI allowed the team to split trial participants into two groups: either slowly or rapidly progressing towards Alzheimer’s disease.
"AI-assisted MRI could potentially detect cancers that humans wouldn’t find otherwise," said the study's lead investigator Felipe Oviedo, Ph.D., a senior research analyst at Microsoft's AI for Good Lab.
In a study published in Nature Communications, researchers at the University of Pennsylvania used a deep-learning system called APEX to sift through a database